CMG Pharmaceutical Co. Ltd (058820) — Free Cash Flow Generation Index
CMG Pharmaceutical Co. Ltd (058820) has a Free Cash Flow Generation Index of -28.51x as of December 2024. Free cash flow of ₩-8.27 Billion represents -29% of operating cash flow (₩290.09 Million). See CMG Pharmaceutical Co. Ltd (058820) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
CMG Pharmaceutical Co. Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for CMG Pharmaceutical Co. Ltd across 11 annual periods. Explore 058820 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for CMG Pharmaceutical Co. Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for CMG Pharmaceutical Co. Ltd. For the full company profile including market capitalisation, see how much is CMG Pharmaceutical Co. Ltd worth.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -108.44x | ₩-31.46 Billion | ₩290.09 Million | ₩31.75 Billion | ▼ -3639.2% |
| 2023 | -2.90x | ₩-11.34 Billion | ₩3.91 Billion | ₩15.25 Billion | ▼ -166.7% |
| 2022 | -1.09x | ₩-5.37 Billion | ₩4.94 Billion | ₩10.31 Billion | ▼ -464.9% |
| 2021 | 0.30x | ₩1.68 Billion | ₩5.63 Billion | ₩3.95 Billion | ▲ +113.1% |
| 2020 | -2.28x | ₩-6.71 Billion | ₩2.94 Billion | ₩9.65 Billion | ▲ +31.7% |
| 2019 | -3.33x | ₩-9.41 Billion | ₩2.82 Billion | ₩8.18 Billion | ▼ -186.1% |
| 2018 | 3.87x | ₩3.43 Billion | ₩886.78 Million | ₩2.55 Billion | ▲ +178.4% |
| 2017 | 1.39x | ₩2.71 Billion | ₩1.95 Billion | ₩760.59 Million | ▲ +3.3% |
| 2016 | 1.35x | ₩3.11 Billion | ₩2.31 Billion | ₩799.00 Million | ▼ -46.3% |
| 2015 | 2.51x | ₩6.05 Billion | ₩2.41 Billion | ₩3.64 Billion | ▼ -82.1% |
| 2014 | 14.00x | ₩10.15 Billion | ₩724.89 Million | ₩9.42 Billion | — |